Cancer exploiting complement: a clue or an exception?
Loveland
Bruce E
BE
Cebon
Jonathan
J
D000818:Animals; D003167:Complement Activation; D015936:Complement C5a / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology*; D006801:Humans; D051379:Mice; D022423:Myeloid Cells / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000473:pathology*; D044087:Receptor, Anaphylatoxin C5a / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D044087:Receptor, Anaphylatoxin C5a; D015936:Complement C5a; D003165:Complement System Proteins